Methods of treating diabetes with albumin-conjugated exendin peptides
US7683030B2 · kind B2 · utility
40Cited by
29References
15Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 11, 2008 |
| Grant date | Mar 23, 2010 |
| Priority date | — |
| Expiry date | Mar 11, 2028 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P3/10
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Modified exendins and exendin agonists having an exendin or exendin agonist linked to one or more polyethylene glycol polymers, for example, and related formulations and dosages and methods of administration thereof are provided. These modified exendins and exendin agonists, compositions and methods are useful in treating diabetes and conditions that would be benefited by lowering plasma glucose or delaying and/or slowing gastric emptying or inhibiting food intake.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.